z-logo
open-access-imgOpen Access
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
Author(s) -
Andrew P. Ambrosy,
Peter S. Pang,
Sadiya S. Khan,
Marvin A. Konstam,
Gregg C. Fonarow,
Brian Traver,
Aldo P. Maggioni,
Thomas D. Cook,
K. Swedberg,
John C. Burnett,
Liliana Grinfeld,
James E. Udelson,
Faı̈ez Zannad,
Mihai Gheorghiade
Publication year - 2013
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs444
Subject(s) - medicine , heart failure , ejection fraction , peripheral edema , placebo , furosemide , vital signs , natriuretic peptide , clinical endpoint , cardiology , confidence interval , randomized controlled trial , surgery , adverse effect , alternative medicine , pathology
Signs and symptoms of congestion are the most common cause for hospitalization for heart failure (HHF). The clinical course and prognostic value of congestion during HHF has not been systemically characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom